Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02XXQ
|
|||
Former ID |
DIB014800
|
|||
Drug Name |
MEDl-557
|
|||
Indication | Respiratory syncytial virus infection [ICD-11: 1C80; ICD-9: 79.6] | Phase 1 | [1] | |
Company |
Astrazeneca; medimmune
|
References | Top | |||
---|---|---|---|---|
REF 1 | Respiratory syncytial virus market. Nat Rev Drug Discov. 2010 Jan;9(1):15-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.